Reduction of neuroinflammation alleviated mouse post bone fracture and stroke memory dysfunction

Area of Science:

• Neuroscience
• Pharmacology
• Stroke Research

Background:

• Tibia fracture exacerbates stroke-induced neuronal injury and memory deficits.
• Alpha-7 nicotinic acetylcholine receptor (α-7 nAchR) activation shows potential in reducing acute neuroinflammation and stroke-related dysfunction.

Purpose of the Study:

• To investigate if activating α-7 nAchR before stroke improves long-term memory in mice with tibia fractures.
• To assess the impact of α-7 nAchR modulation on neuroinflammation, neuronal injury, and cognitive/sensorimotor functions post-stroke.

Main Methods:

• Mice with tibia fractures received saline, an α-7 nAchR agonist (PHA-568487), or an antagonist (methyllycaconitine) 6 hours before induced stroke.
• Sensorimotor function was evaluated using adhesive removal and corner tests.
• Long-term memory was assessed via Y-maze and novel object recognition tests over 8 weeks.

Main Results:

• PHA-568487 treatment reduced inflammatory markers (CD68+ cells), neuronal injury, and sensorimotor deficits.
• The agonist improved long-term memory function and reduced hippocampal and white matter damage.
• Methyllycaconitine exacerbated these negative outcomes, while PHA-568487 promoted neuron proliferation.

Conclusions:

• Reducing neuroinflammation via α-7 nAchR activation shortly before stroke mitigates neuronal damage.
• This therapeutic strategy shows promise for improving sensorimotor and long-term memory dysfunction following stroke in the context of a tibia fracture.
• Targeting α-7 nAchR represents a potential therapeutic avenue for stroke patients with concurrent injuries.